» Articles » PMID: 33994716

Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens Survival in Decompensated Liver Cirrhosis

Overview
Publisher Elsevier
Specialty Gastroenterology
Date 2021 May 17
PMID 33994716
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis. However, the incidence and the real impact of SBP in determining patient survival rates remain unclear. This study aims to evaluate the incidence and risk factors for SBP development and the role of SBP in predicting transplant-free survival.

Methods: Two hundred two consecutive patients underwent 492 paracenteses with biochemical and microbiological analysis of the ascitic fluid. When multiple paracenteses had been performed on a given patient, the first SBP-positive paracentesis or the first paracentesis conducted when none was diagnostic for SBP was included in the study.

Results: SBP was detected in 28 of 202 (13.9%) patients; in 26 of 28 patients, the neutrophil count in the ascitic fluid was ≥250 cells/μl, and in 15 of 28 patients, the cultures were positive. Variables independently associated with SBP were as follows: a higher model of end-stage liver disease (MELD) score, the serum glucose value, elevated CRP serum levels, and higher potassium serum levels. Overall, the median (range) transplant-free survival was 289 (54-1253) days. One hundred (49.5%) patients died, whereas 35 patients (17.3%) underwent liver transplantation. Independent predictors of death or liver transplantation were a higher MELD score and the development of SBP, especially if it was antibiotic-resistant or recurrent SBP.

Conclusion: The occurrence of SBP is associated with more severe liver dysfunction in conjunction with the presence of inflammation. Unlike the occurrence of SBP , failure of first-line antibiotic treatment and SBP recurrence appear to strongly influence the mortality rate.

Citing Articles

Variables associated with antibiotic administration for performing paracentesis among patients with ascites in a community hospital.

Pandya N, Pendyala N, Fogel J, Szurnicki P, Choudhry M, Eng A Clin Exp Hepatol. 2024; 10(1):47-52.

PMID: 38765905 PMC: 11100336. DOI: 10.5114/ceh.2024.136215.


Human Amniotic MSC Response in LPS-Stimulated Ascites from Patients with Cirrhosis: FOXO1 Gene and Th17 Activation in Enhanced Antibacterial Activation.

Pampalone M, Cuscino N, Iannolo G, Amico G, Ricordi C, Vitale G Int J Mol Sci. 2024; 25(5).

PMID: 38474048 PMC: 10932448. DOI: 10.3390/ijms25052801.


Serum copeptin is associated with major complications of liver cirrhosis and spontaneous bacterial peritonitis.

Abudeif A, Hashim M, Ahmed N, Ahmed A Clin Exp Hepatol. 2023; 9(1):71-78.

PMID: 37064833 PMC: 10090990. DOI: 10.5114/ceh.2023.125970.


Therapeutic effect of autologous bone marrow cells injected into the liver under the guidance of B‑ultrasound in the treatment of HBV‑related decompensated liver cirrhosis.

Li L, Si Y, Cheng M, Lang L, Li A, Liu B Exp Ther Med. 2022; 24(4):633.

PMID: 36160909 PMC: 9468850. DOI: 10.3892/etm.2022.11570.


Overview of Complications in Cirrhosis.

Premkumar M, Anand A J Clin Exp Hepatol. 2022; 12(4):1150-1174.

PMID: 35814522 PMC: 9257866. DOI: 10.1016/j.jceh.2022.04.021.


References
1.
. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018; 69(2):406-460. DOI: 10.1016/j.jhep.2018.03.024. View

2.
Christou L, Pappas G, Falagas M . Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol. 2007; 102(7):1510-7. DOI: 10.1111/j.1572-0241.2007.01286.x. View

3.
Schwabl P, Bucsics T, Soucek K, Mandorfer M, Bota S, Blacky A . Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites. Liver Int. 2015; 35(9):2121-8. DOI: 10.1111/liv.12795. View

4.
Oladimeji A, Temi A, Adekunle A, Taiwo R, Ayokunle D . Prevalence of spontaneous bacterial peritonitis in liver cirrhosis with ascites. Pan Afr Med J. 2013; 15:128. PMC: 3830462. DOI: 10.11604/pamj.2013.15.128.2702. View

5.
Piano S, Singh V, Caraceni P, Maiwall R, Alessandria C, Fernandez J . Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide. Gastroenterology. 2018; 156(5):1368-1380.e10. DOI: 10.1053/j.gastro.2018.12.005. View